Media

The Biotechnology Industry Organization (BIO) today announced that it will showcase a series of unique sessions at this year’s Livestock Biotech Summit...
Sessions to focus on the FDA Breakthrough Therapy Designation Process, IPO Market, and BioCentury’s Back to School issue

Press Releases

Mar 7 2001
WASHINGTON, D.C. (March 7, 2001) -- The Biotechnology Industry Organization (BIO) today issued the following statement following the Environmental Protection...
Mar 6 2001
Washington, D.C. (March 6, 2001) -- The Biotechnology Industry Organization (BIO) today issued the following statement following Senate introduction of a bill...
Mar 1 2001
Washington, D.C. (March 1, 2001) -- The Biotechnology Industry Organization (BIO) will begin a six month television advertising campaign this weekend on both...
Feb 22 2001
WASHINGTON, DC (February 22, 2001) --Michael J. Werner, director of federal government relations and bioethics counsel for the Biotechnology Industry...
Feb 16 2001
Washington, D.C. – A record 32 biotechnology drugs, vaccines and new indications for existing medicines were approved by the U.S. Food and Drug Administration...
Feb 15 2001
WASHINGTON, D.C. (February 15, 2001) -- Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement today on...
Feb 14 2001
WASHINGTON, D.C. (February 14, 2001) – U.S. Sen. Tim Hutchinson (R-Arkansas) and Newt Gingrich, former Speaker of the U.S. House of Representatives, will be...
Feb 12 2001
WASHINGTON, D.C. (February 12, 2001) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on...
Feb 1 2001
WASHINGTON, D.C. (February 1, 2001) – Following recent announcements by certain groups of plans to clone human beings, the Biotechnology Industry Organization...